Coverage complications are not unusual in the U.S. healthcare system. But the challenge is magnified for these obesity ...
Metsera’s GLP-1 peptide has a long half-life, meaning it could be administered once a month. The company is ready to scale up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results